Matinas BioPharma
MTNB
#10151
Rank
A$4.31 M
Marketcap
$0.85
Share price
1.90%
Change (1 day)
-94.28%
Change (1 year)

Matinas BioPharma (MTNB) - Cash on Hand

Cash on Hand as of September 2024 : A$17.29 Million

According to Matinas BioPharma's latest financial reports the company has A$17.29 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Matinas BioPharma - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$42.26 M-38.25%
2021-12-31A$68.44 M-10.31%
2020-12-31A$76.31 M92.37%
2019-12-31A$39.67 M124.53%
2018-12-31A$17.66 M88.79%
2017-12-31A$9.35 M64.32%
2016-12-31A$5.69 M28.58%
2015-12-31A$4.42 M39.93%
2014-12-31A$3.16 M-73.95%
2013-12-31A$12.15 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.43 B 2,423.10%๐Ÿ‡บ๐Ÿ‡ธ USA